SCHRODINGER INC

NASDAQ: SDGR (Schrodinger, Inc.)

Last update: 12 Feb, 12:07PM

11.76

-0.22 (-1.84%)

  • 1D -1.84%
  • 5D -3.21%
  • 1M 3.98%
  • 6M -36.67%
  • YTD -34.59%
  • 1Y -48.35%
  • 5Y -85.46%
Previous Close 11.98
Open 12.09
Volume 1,595,807
Avg. Volume (3M) 1,085,168
Market Cap 866,296,960
Price / Sales 3.72
Price / Book 2.63
52 Weeks Range
11.15 (-5%) — 28.47 (142%)
Earnings Date 25 Feb 2026
Profit Margin -83.39%
Operating Margin (TTM) -85.45%
Diluted EPS (TTM) -2.63
Quarterly Revenue Growth (YOY) 62.70%
Total Debt/Equity (MRQ) 31.15%
Current Ratio (MRQ) 3.45
Operating Cash Flow (TTM) 25.97 M
Levered Free Cash Flow (TTM) -17.73 M
Return on Assets (TTM) -16.27%
Return on Equity (TTM) -43.33%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bearish Bearish
Health Information Services (Global) Bearish Bearish
Stock Schrodinger, Inc. Bearish Bearish

AIStockmoo Score

1.7
Analyst Consensus 3.0
Insider Activity 1.0
Price Volatility 3.0
Technical Moving Averages 3.5
Technical Oscillators -2.0
Average 1.70

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
SDGR 866 M - - 2.63
OMCL 2 B - 1,027.50 1.56
PGNY 2 B - 33.66 2.71
CERT 1 B - 92.71 1.06
GDRX 823 M - 29.63 1.23
HSTM 603 M 0.46% 29.87 1.81

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Sector Healthcare
Industry Health Information Services
Investment Style Small Core
% Held by Insiders 2.63%
% Held by Institutions 101.76%

Ownership

Name Date Shares Held
Gates Foundation Trust 30 Sep 2025 6,981,664
52 Weeks Range
11.15 (-5%) — 28.47 (142%)
Price Target Range
18.00 (53%) — 25.00 (112%)
High 25.00 (Keybanc, 112.59%) Buy
Median 24.00 (104.08%)
Low 18.00 (UBS, 53.06%) Hold
Average 22.75 (93.45%)
Total 3 Buy, 1 Hold
Avg. Price @ Call 18.55
Firm Date Target Price Call Price @ Call
Keybanc 08 Jan 2026 25.00 (112.59%) Buy 18.61
TD Cowen 08 Jan 2026 24.00 (104.08%) Buy 18.61
UBS 07 Jan 2026 18.00 (53.06%) Hold 18.77
B of A Securities 15 Dec 2025 24.00 (104.08%) Buy 18.21
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
ABEL ROBERT LORNE 12.15 13.12 36,512 442,360
AKINSANYA KAREN 12.15 12.59 54,331 658,920
AKLIAN MANNIX VARTAN 12.15 - 17,130 208,130
FARID RAMY 12.15 12.59 108,892 1,319,816
FRIESNER RICHARD - - 0 0
HERMAN JENNY 12.15 12.89 8,207 98,674
JAIN RACHIT 12.15 13.03 15,499 186,878
LORTON KENNETH PATRICK 12.15 13.03 36,590 443,493
TRAN YVONNE 12.15 13.03 29,824 361,399
Aggregate Net Quantity 306,985
Aggregate Net Value ($) 3,719,669
Aggregate Avg. Buy ($) 12.15
Aggregate Avg. Sell ($) 12.83
Insider Range ($)
12.15 (3%) — 13.12 (11%)
Name Holder Date Type Quantity Price Value ($)
HERMAN JENNY Officer 06 Mar 2026 Automatic sell (-) 608 12.74 7,746
LORTON KENNETH PATRICK Officer 05 Mar 2026 Automatic sell (-) 1,222 13.03 15,923
AKINSANYA KAREN Officer 05 Mar 2026 Automatic sell (-) 1,366 13.03 17,799
FARID RAMY Officer 05 Mar 2026 Automatic sell (-) 3,661 13.03 47,703
TRAN YVONNE Officer 05 Mar 2026 Automatic sell (-) 1,094 13.03 14,255
JAIN RACHIT Officer 05 Mar 2026 Automatic sell (-) 1,631 13.03 21,252
HERMAN JENNY Officer 05 Mar 2026 Automatic sell (-) 775 13.03 10,098
ABEL ROBERT LORNE Officer 04 Mar 2026 Automatic sell (-) 1,300 13.12 17,056
LORTON KENNETH PATRICK Officer 02 Mar 2026 Acquired (+) 37,812 12.15 459,416
AKINSANYA KAREN Officer 02 Mar 2026 Acquired (+) 57,903 12.15 703,521
AKINSANYA KAREN Officer 02 Mar 2026 Automatic sell (-) 2,206 12.15 26,803
FARID RAMY Officer 02 Mar 2026 Acquired (+) 118,113 12.15 1,435,073
FARID RAMY Officer 02 Mar 2026 Automatic sell (-) 5,560 12.15 67,554
TRAN YVONNE Officer 02 Mar 2026 Acquired (+) 30,918 12.15 375,654
HERMAN JENNY Officer 02 Mar 2026 Acquired (+) 9,590 12.15 116,519
ABEL ROBERT LORNE Officer 02 Mar 2026 Acquired (+) 37,812 12.15 459,416
FRIESNER RICHARD Director 02 Mar 2026 Option execute 160,527 - -
JAIN RACHIT Officer 02 Mar 2026 Acquired (+) 17,130 12.15 208,130
AKLIAN MANNIX VARTAN Officer 02 Mar 2026 Acquired (+) 17,130 12.15 208,130
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria